THE MCCULLOUGH REPORT

Novavax COVID-19 Vaccine—A Possibly Safer Choice but Likely Obsolete

06.14.2022 - By Dr. Peter McCulloughPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

The technology differs from Pfizer and Moderna’s shots, which were the first ones using messenger RNA technology to receive FDA approval and have resulted in catastrophic rates of injury, disability, and death. In the Novavax clinical trial experience, there were no hospitalizations or deaths due to COVID-19...

More episodes from THE MCCULLOUGH REPORT